There was so little unity up to March this year, and little progress in regards to the clinic at that point.
RAC seemed to have got the ball rolling since then, albiet the SP had dropped.
Now there has been unrest again, and I doubt much unity within the board.
I feel like a few longs have gotten tired of the same old story, and question motives, but will hold to see this unfold, for no reason other than knowing Bisantrene works!
Even if Tillett does have shareholders best interests at heart, it doesn't mean he will always make the right decisions.
For instance, if a BP wants to buy into RAC with large equity share at $5, is Dr T not entertaining this idea in the best interests of shareholders? I guarantee the responses to that question would be divided.
RAC Price at posting:
81.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)